Evidence map›Paper›PMID 41811963›Full record

ArticleScience advances2026

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.

Bruno Beernaert, Rose L Jady-Clark, Parin Shah, Erik Ramon-Gil, Nora M Lawson, Zack D Brodtman, Somnath Tagore, Frederik Stihler, Alfie S Carter, Shannique Clarke and 22 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Bruno BeernaertDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-6219-6163
Rose L Jady-ClarkDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0009-0000-4065-5990
Parin ShahDepartment of Medicine, Division of Hematology and Medical Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
Erik Ramon-GilFaculty of Medical Sciences, Newcastle University, Newcastle, UK.ORCID 0000-0002-6397-0130
Nora M LawsonDepartment of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0009-0000-1656-7288
Zack D BrodtmanDepartment of Medicine, Division of Hematology and Medical Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.ORCID 0009-0009-6562-0626
Somnath TagoreDepartment of Medicine, Division of Hematology and Medical Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.ORCID 0000-0001-9603-1263
Frederik StihlerDepartment of Medicine, Division of Hematology and Medical Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.ORCID 0009-0003-5864-7800
Alfie S CarterDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0009-0000-6555-8732
Shannique ClarkeDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0003-4892-6171
Tong LiuDepartment of Oncology, University of Oxford, Oxford, UK.
Winston M ZhuDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-3171-938X
Juliet E MartinDepartment of Oncology, University of Oxford, Oxford, UK.
Erkin ErdalDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-0046-8362
Alistair EastonDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0001-8148-5406
Leticia CampoDepartment of Oncology, University of Oxford, Oxford, UK.
Molly BrowneDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-4560-5623
Stephen AshLudwig Institute for Cancer Research, University of Oxford, Oxford, UK.ORCID 0000-0002-2970-3821
Rabial Q RajaFaculty of Medical Sciences, Newcastle University, Newcastle, UK.ORCID 0009-0005-6896-5866
Nicola WaddellQIMR Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0002-3950-2476
Tom CrosbyVelindre Cancer Centre, Velindre Hospital, Cardiff, UK.
Simon R LordDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0001-7946-5609
Derek A MannFaculty of Medical Sciences, Newcastle University, Newcastle, UK.ORCID 0000-0003-0950-243X
Ignacio MeleroCentre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-1360-348X
Carlos E de AndreaDepartments of Pathology, Oncology and Immunology, Clínica Universidad de Navarra (CCUN), Pamplona, Spain.ORCID 0000-0002-7628-8050
Andréa E TijhuisEuropean Research Institute for the Biology of Ageing, University of Groningen, Groningen, Netherlands.ORCID 0000-0001-8150-3061
Floris FoijerEuropean Research Institute for the Biology of Ageing, University of Groningen, Groningen, Netherlands.ORCID 0000-0003-0989-3127
Ester M HammondDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-2335-3146
Kadir C AkdemirDepartment of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jack LeslieFaculty of Medical Sciences, Newcastle University, Newcastle, UK.ORCID 0000-0001-6443-2396
Benjamin IzarDepartment of Medicine, Division of Hematology and Medical Oncology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.ORCID 0000-0003-2379-6702
Eileen E ParkesDepartment of Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-7855-3698

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal instability (CIN), a pervasive feature of esophageal adenocarcinoma (EAC), drives tumor aggressiveness and metastasis. CIN stimulates the cGAS-STING pathway, typically linked to antitumor immunity. However, despite the high CIN burden in EAC, the cGAS-STING pathway remains largely intact. To address this paradox, we interrogated multiple esophageal cancer models, finding myeloid-attracting chemokines-with

Indexed as

AdenocarcinomaChemokinesChromosomal InstabilityEsophageal NeoplasmsMyeloid CellsNucleotidyltransferasesTumor MicroenvironmentAnimalsCell Line, TumorcGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseHumansInterleukin-8Membrane ProteinsSignal TransductionSTING ProteincGAS protein, humanChemokinesCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseInterleukin-8Membrane ProteinsNucleotidyltransferasesSTING1 protein, humanSTING Protein

Identifiers

PMID41811963
PMCPMC12978254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.